Ignite Creation Date:
2025-12-24 @ 2:14 PM
Ignite Modification Date:
2026-03-09 @ 11:00 PM
Study NCT ID:
NCT03761095
Status:
COMPLETED
Last Update Posted:
2024-03-15
First Post:
2018-11-29
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Unesbulin (PTC596) in Combination With Dacarbazine in Participants With Advanced Leiomyosarcoma (LMS)
Sponsor:
PTC Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PTC596-ONC-007-LMS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None